Santhera Pharmaceuticals

Recent Finacing

Debt ext

Recent Raise

$39.1M

Santhera Pharmaceuticals is a Swiss company developing and commercializing AGAMREE and therapies for rare neuromuscular and pulmonary diseases, with licensing in North America and China and commercialization in Europe.

Founded 2004

Basel-Landschaft, Switzerland

51-100

Publicly Traded

santhera.com

Highlights

Focus Areas

Biotechnology

Health Care

Pharmaceutical

Recent Investors

Financials

$39.2M

Total Raised

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at Santhera Pharmaceuticals.